Tumor site-directed therapy for hepatocellular carcinoma using monoclonal antibodies against hepatoma-associated antigens.
Shouval
D
D
Liver Unit, Hadassah University Hospital, Jerusalem, Israel.
Adler
R
R
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000951:Antigens, Neoplasm / Q000276:immunology*; D006528:Carcinoma, Hepatocellular / Q000276:immunology / Q000628:therapy*; D006801:Humans; D000922:Immunotoxins / Q000627:therapeutic use; D008113:Liver Neoplasms / Q000276:immunology / Q000628:therapy*; D016719:Radioimmunodetection; D016499:Radioimmunotherapy
D000911:Antibodies, Monoclonal; D000951:Antigens, Neoplasm; D000922:Immunotoxins